ロード中...
Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
BACKGROUND: PCDH8 is a tumor suppressor that regulates cell adhesin, proliferation, and migration. It is often inactivated by aberrant promoter methylation in several human cancers, including clear cell renal cell carcinoma (CCRCC). The clinical significance of PCDH8 methylation in CCRCC remains unc...
保存先:
| 出版年: | Med Sci Monit |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4251547/ https://ncbi.nlm.nih.gov/pubmed/25416427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.892433 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|